Skip to Content

Merck KGaA ADR MKKGY Stock Quote

| Rating as of


Market Open

| Currency in USD

  • Last Close 33.36
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Investment Style Large Blend
  • Day Range 32.53  –  33.19
  • Year Range 30.16  –  43.54
  • Market Cap 70.7168 Bil
  • Volume / Avg 28,709.0 /  68,890.4
  • Price / Sales 3.14
  • Price / Book 2.50
  • Forward Div Yield 1.48%
  • Trailing Div Yield 1.49%

Morningstar‘s Stock Analysis MKKGY

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


A Narrow Moat Surrounds Merck's Diverse Life Science, Healthcare, and Electronics Portfolio

Julie Utterback Senior Equity Analyst

Business Strategy and Outlook

| Julie Utterback |

Merck KGaA has made a series of acquisitions and divestitures in the past decade or so to position the group for solid long-term growth in three key segments: life sciences, performance materials, and healthcare. However, after robust results during the pandemic due to COVID-19-related demand particularly in its life sciences business, we think the company's intermediate-term growth may soften toward more historic norms.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics MKKGY

Company Profile MKKGY

Business Description

Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Frankfurter Strasse 250
Darmstadt, HE, 64293, DEU
Industry Drug Manufacturers - Specialty & Generic
Employees 63,712

Related Articles MKKGY

Competitors & Peers MKKGY

Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of MKKGY’s competitive advantage.

Merck KGaA ADR


Biogen Inc


Danaher Corp


Thermo Fisher Scientific Inc

−$0.78 (2.34%) −$2.05 (0.79%) −$1.96 (0.79%) −$4.56 (0.91%)
Market Cap
70.72 Bil37.08 Bil181.08 Bil191.85 Bil
Drug Manufacturers - Specialty & Generic Drug Manufacturers - General Diagnostics & Research Diagnostics & Research

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Merck KGaA ADR Stock

Yes. MKKGY has a forward dividend yield of 1.46%. See MKKGY’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

MKKGY’s market cap is 70.72 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

MKKGY’s stock style is Large Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

MKKGY’s price/sales is 3.14.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

MKKGY’s price/forward earnings is 22.52.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

MKKGY’s price/book is 2.50.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See MKKGY’s valuation ratios compared to the Market Index.

MKKGY’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare MKKGY’s historical performance against its industry peers and the overall market.